Clinical Trial

Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis

Name: Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis — clinical trial record (NCT07580716)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, randomized, double-blind, placebo-controlled, Phase IIb study to evaluate intra-articular (IA) injections of Allocetra in participants with moderate-to-severe age related symptomatic primary knee osteoarthritis (OA).

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-21

Trial Details

NCT Number	NCT07580716
Lead Sponsor	Enlivex Therapeutics Ltd. Collaborators: Nordic Bioscience Clinical Development (NBCD)
Conditions	Primary Knee Osteoarthritis
Enrollment	270 participants
Start Date	2026-05-01
Primary Completion	2027-02 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-17